Company: ZLAB
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001628280-25-008409
Chunk: 62

Company: Zai Lab Ltd
Filing Date: 2025-02-27
Form: 10-K
Item: Item 16
Chunk 62
---
 the full amount was subsequently withdrawn by Zai Lab Shanghai in February 2025. The working capital loan has a one-year term and is subject to a floating interest rate, which is subject to adjustment every three months.In February 2025, upon the maturity of a portion of the short-term debt with BOC Pudong Branch (see Note 12), Zai Lab Shanghai repaid RMB340.0 million (approximately $46.9 million) of the loan balance.

F-38

Schedule I — Condensed Financial Information of RegistrantZai Lab LimitedFinancial Information of Parent CompanyCondensed Balance Sheets(in thousands of $, except for number of shares and per share data)December 31,20242023AssetsCurrent assets:Cash and cash equivalents98,755 565,981 Restricted Cash, current100,000 — Short-term investments330,000 — Prepayments and other current assets5,227 7,423 Total current assets533,982 573,404 Investment in subsidiaries309,901 224,954 Total assets843,883 798,358 Liabilities and shareholders’ equityLiabilitiesCurrent liabilities:Other current liabilities2,985 2,240 Total current liabilities2,985 2,240 Total liabilities2,985 2,240 Shareholders’ equityOrdinary shares (par value of $0.000006 per share; 5,000,000,000 shares authorized, 1,082,614,740 and 977,151,270 shares issued as of December 31, 2024 and 2023, respectively; 1,077,702,540 and 972,239,070 shares issued and outstanding as of December 31, 2024 and 2023, respectively)7 6 Additional paid-in capital3,264,295 2,975,302 Accumulated deficit(2,453,083)(2,195,980)Accumulated other comprehensive income50,515 37,626 Treasury stock(20,836)(20,836)Total shareholders’ equity840,898 796,118 Total liabilities and shareholders’ equity843,883 798,358 

F-39

Schedule I — Condensed Financial Information of RegistrantZai Lab Limited Financial Information of Parent CompanyCondensed Statements of Operations and Comprehensive Loss(in thousands of $)Year Ended December 31,202420232022Operating Expenses:Research